InspireMD

InspireMD is a NASDAQ-listed (NSPR) commercial-stage medical device company dedicated to helping prevent stroke and save lives through innovative carotid intervention technology. The company's flagship product, CGuard, is the only mesh-covered carotid stent on the market, featuring a dual-layer design with a finely woven MicroNet mesh covering designed to prevent carotid plaque prolapse during stenting procedures. CGuard has demonstrated the lowest independently adjudicated 30-day and 1-year major adverse event rates of any pivotal carotid artery stenting study. InspireMD focuses on empowering physicians and patients to choose carotid stenting without compromise, advancing stroke prevention globally through evidence-based innovation and a growing international commercial footprint.